Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Updates in therapy for uterine serous carcinoma

8 Nov 2012

Abstract excerpt

PURPOSE OF REVIEW: Uterine serous carcinoma (USC) is a highly aggressive variant of endometrial cancer with distinct molecular pathogenesis. This review summarizes the rationale behind current clinical approaches, as well as advances made in 2012 toward the elucidation of underlying pathway aberrations and development of targeted therapies that exploit these unique characteristics. RECENT FINDINGS: Within the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis and VEGF in Cancer
Share to Endometrial and Cervical Cancer Treatments
Share to PI3K/AKT/mTOR signaling in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23138439
DOI: 10.1097/gco.0b013e32835af98d

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Updates in therapy for uterine serous carcinomaPMID 23138439Read ↗

Novel targeted therapies in uterine serous carcinoma, an aggressive variant of endometrial cancer.Semantic proximity Read ↗

Uterine serous carcinoma: Molecular features, clinical management, and new and future therapies.Semantic proximity Read ↗

Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.Semantic proximity Read ↗

Identification of potential therapeutic targets by molecular profiling of 628 cases of uterine serous carcinoma.Semantic proximity Read ↗

Recent Advances in Endometrial CancerSemantic proximity Read ↗

Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment ChangesSemantic proximity Read ↗

Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo.Semantic proximity Read ↗

Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses.Semantic proximity Read ↗

Minireview: Human Ovarian Cancer: Biology, Current Management, and Paths to Personalizing TherapySemantic proximity Read ↗

The Molecular Biology of Endometrial Cancers and the Implications for Pathogenesis, Classification, and Targeted TherapiesSemantic proximity Read ↗

Endometrial cancer: molecular and therapeutic aspectsSemantic proximity Read ↗

Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord–Stromal Tumors: A Contemporary ReviewSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.